SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia.
Mathen
D
D
Department of Clinical Neurology, Institute of Neurology, University College London, UK.
Marsden
C D
CD
Bhatia
K P
KP
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D004421:Dystonia / Q000139:chemically induced* / Q000188:drug therapy*; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013315:Stress, Psychological / Q000188:drug therapy / Q000523:psychology
D000978:Antiparkinson Agents; D005473:Fluoxetine; D007980:Levodopa; D017367:Selective Serotonin Reuptake Inhibitors